Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
Tax withholdingCommon Stock | 3,813 | $20.66 | $78,776.58 |
DisclosureSEC source: 0001757073-25-000014 · wk-form4_1740695247.xml · nonDerivative · entry 1 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,907 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSUs"). Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:52 UTC |
Befidi RobertPresident, Diagnostics
|
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative | 1,151 | $20.52 | $23,618.52 |
DisclosureSEC source: 0001757073-25-000004 · wk-form4_1738705954.xml · derivative · entry 1 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,151 Underlying: Common Stock · 1,151 shares Expires not disclosed F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day). F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day). F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 16:52 UTC |
Kaabi Faez CChief Accounting Officer
|
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative | 689 | $20.52 | $14,138.28 |
DisclosureSEC source: 0001757073-25-000002 · wk-form4_1738705932.xml · derivative · entry 1 Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,854 Underlying: Common Stock · 689 shares Expires not disclosed F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntarily defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntarily defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day). F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day). F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 16:52 UTC |
Nance Mark EGeneral Counsel
|
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative | 965 | $20.52 Strike: $0.00 | $19,801.80 |
DisclosureSEC source: 0001757073-25-000003 · wk-form4_1738705944.xml · derivative · entry 1 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,581 Underlying: Common Stock · 965 shares Expires not disclosed F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day). F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day). F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:52 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
GrantExecutive Deferred Incentive Program - Envista Stock Fund · Derivative | 3,152 | $20.52 Strike: $0.00 | $64,679.04 |
DisclosureSEC source: 0001757073-25-000001 · wk-form4_1738705921.xml · derivative · entry 1 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,438 Underlying: Common Stock · 3,152 shares Expires not disclosed F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F2 · derivative.exercise_date: All contributions to the reporting person's EDIP Stock Fund are 80% vested and will vest at 10% each subsequent year on 1/1 until he reaches 10 years of EDIP participation or retirement eligibility. Upon termination of employment, the EDIP Stock Fund balance is settled in shares of Envista common stock. F2 · derivative.expiration_date: All contributions to the reporting person's EDIP Stock Fund are 80% vested and will vest at 10% each subsequent year on 1/1 until he reaches 10 years of EDIP participation or retirement eligibility. Upon termination of employment, the EDIP Stock Fund balance is settled in shares of Envista common stock. F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "EDIP Stock Fund") in the reporting person's Executive Deferred Incentive Program (the "EDIP") account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last trading day of the prior year. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day). Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 21:10 UTC |
Keel Paul ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 53,996 | $20.94 | $1,130,676.24 |
DisclosureSEC source: 0001757073-24-000079 · wk-form4_1730754641.xml · nonDerivative · entry 1 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 348,609 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU") Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:25 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
Tax withholdingCommon Stock | 812 | $19.00 | $15,428.00 |
DisclosureSEC source: 0001757073-24-000076 · wk-form4_1726777533.xml · nonDerivative · entry 1 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,720 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| August 25, 2024 Filed Aug 27, 2024 21:32 UTC |
Befidi RobertPresident, Diagnostics
|
GrantPerformance Option · Derivative | 70,400 | $0.00 Strike: $18.70 | $0.00 |
DisclosureSEC source: 0001757073-24-000071 · wk-form4_1724794212.xml · derivative · entry 2 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,400 Underlying: Common Stock · 70,400 shares Expires 2034-08-25 F2 · derivative.exercise_date: Consists of Performance Options that have a 3-year cliff vest, subject to performance stock price attainment of 133% of the grant date price for 20 consecutive trading days. Read SEC document |
| August 25, 2024 Filed Aug 27, 2024 21:32 UTC |
Befidi RobertPresident, Diagnostics
|
Tax withholdingCommon Stock | 3,454 | $18.70 | $64,589.80 |
DisclosureSEC source: 0001757073-24-000071 · wk-form4_1724794212.xml · nonDerivative · entry 1 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,791 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| August 25, 2024 Filed Aug 27, 2024 21:24 UTC |
Hammes Eric D.Chief Financial Officer
|
GrantCommon Stock | 64,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000070 · wk-form4_1724793810.xml · nonDerivative · entry 1 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,707 F1 · shares: Consists of Restricted Stock Units (" RSUs") that will vest as to 21,391 shares of Issuer's common stock on August 25, 2025 and as to 21,392 shares of Issuer's common stock on each of August 25, 2026 and 2027, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| August 25, 2024 Filed Aug 27, 2024 21:40 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantPerformance Option · Derivative | 485,680 | $0.00 Strike: $18.70 | $0.00 |
DisclosureSEC source: 0001757073-24-000073 · wk-form4_1724794822.xml · derivative · entry 1 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 485,680 Underlying: Common Stock · 485,680 shares Expires 2034-08-25 F1 · derivative.exercise_date: Consists of Performance Options that have a 3-year cliff vest, subject to performance stock price attainment of 133% of the grant date price for 20 consecutive trading days. Read SEC document |
| August 25, 2024 Filed Aug 27, 2024 17:43 UTC |
Nance Mark EGeneral Counsel
|
GrantPerformance Option · Derivative | 95,240 | $0.00 Strike: $18.70 | $0.00 |
DisclosureSEC source: 0001757073-24-000074 · wk-form4_1724794990.xml · derivative · entry 1 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,240 Underlying: Common Stock · 95,240 shares Expires 2034-08-25 F1 · derivative.exercise_date: Consists of Performance Options that have a 3-year cliff vest, subject to performance stock price attainment of 133% of the grant date price for 20 consecutive trading days. Read SEC document |
| August 25, 2024 Filed Aug 27, 2024 21:37 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
GrantPerformance Option · Derivative | 57,980 | $0.00 Strike: $18.70 | $0.00 |
DisclosureSEC source: 0001757073-24-000072 · wk-form4_1724794638.xml · derivative · entry 1 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,980 Underlying: Common Stock · 57,980 shares Expires 2034-08-25 F1 · derivative.exercise_date: Consists of Performance Options that have a 3-year cliff vest, subject to performance stock price attainment of 133% of the grant date price for 20 consecutive trading days. Read SEC document |
| August 13, 2024 Filed Aug 14, 2024 20:40 UTC |
Keel Paul ADirector · Chief Executive Officer
|
PurchaseCommon Stock | 30,000 | $16.87 | $506,100.00 |
DisclosureSEC source: 0001757073-24-000069 · wk-form4_1723668014.xml · nonDerivative · entry 1 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,605 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.37 to $17.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 22:01 UTC |
Hammes Eric D.Chief Financial Officer
|
PurchaseCommon Stock | 24,532 | $16.33 | $400,607.56 |
DisclosureSEC source: 0001757073-24-000068 · wk-form4_1723586463.xml · nonDerivative · entry 1 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,532 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.26 to $16.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 16:12 UTC |
Nance Mark EGeneral Counsel
|
Tax withholdingCommon Stock | 491 | $15.94 | $7,826.54 |
DisclosureSEC source: 0001757073-24-000064 · wk-form4_1721247150.xml · nonDerivative · entry 1 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,481 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 20:32 UTC |
Keller StephenPrincipal Financial Officer
|
GrantCommon Stock | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000062 · wk-form4_1719520349.xml · nonDerivative · entry 1 Keller Stephen · CIK 0001993880 · Principal Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,803 F1 · balance_after: Consists of Restricted Stock Units ("RSU") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| May 25, 2024 Filed May 29, 2024 20:23 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantPerformance Share Unit · Derivative | 205,265 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000057 · wk-form4_1717014217.xml · derivative · entry 5 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,265 Underlying: Common Stock · 205,265 shares Expires not disclosed F5 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period ending on December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F5 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period ending on December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F5 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period ending on December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| May 25, 2024 Filed May 29, 2024 20:23 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 164,560 | $0.00 Strike: $18.25 | $0.00 |
DisclosureSEC source: 0001757073-24-000057 · wk-form4_1717014217.xml · derivative · entry 4 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,560 Underlying: Common Stock · 164,560 shares Expires 2034-05-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| May 25, 2024 Filed May 29, 2024 20:23 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 696,210 | $0.00 Strike: $18.25 | $0.00 |
DisclosureSEC source: 0001757073-24-000057 · wk-form4_1717014217.xml · derivative · entry 3 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 696,210 Underlying: Common Stock · 696,210 shares Expires 2034-05-25 F3 · derivative.exercise_date: This Option will vest as to 232,070 shares of Issuer common stock on each of November 1, 2024, 2025 and 2026, subject to continued service through each such date. Read SEC document |
| May 25, 2024 Filed May 29, 2024 20:23 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantCommon Stock | 301,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000057 · wk-form4_1717014217.xml · nonDerivative · entry 2 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,605 F2 · balance_after: Consists of RSUs that will vest as to 100,456 shares of Issuer common stock on November 1, 2024, and as to 100,457 shares of Issuers common stock on each of November 1, 2025 and 2026, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock Read SEC document |
| May 25, 2024 Filed May 29, 2024 20:23 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantCommon Stock | 71,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000057 · wk-form4_1717014217.xml · nonDerivative · entry 1 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,235 F1 · balance_after: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| May 25, 2024 Filed May 29, 2024 20:24 UTC |
Conley EricSVP, Orthodontics
|
Tax withholdingCommon Stock | 642 | $18.25 | $11,716.50 |
DisclosureSEC source: 0001757073-24-000058 · wk-form4_1717014231.xml · nonDerivative · entry 1 Conley Eric · CIK 0001966479 · SVP, Orthodontics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,223 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:32 UTC |
Jain VivekDirector
|
GrantCommon Stock | 10,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000050 · wk-form4_1716496341.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,165 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:32 UTC |
TSINGOS CHRISTINE ADirector
|
GrantCommon Stock | 10,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000049 · wk-form4_1716496330.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,150 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:34 UTC |
Raskas DanielDirector
|
GrantCommon Stock | 10,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000053 · wk-form4_1716496434.xml · nonDerivative · entry 1 Raskas Daniel · CIK 0001306860 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,230 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:35 UTC |
GALLAHUE KIERANDirector
|
GrantCommon Stock | 10,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000055 · wk-form4_1716496479.xml · nonDerivative · entry 1 GALLAHUE KIERAN · CIK 0001308428 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,230 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:33 UTC |
Huennekens R ScottDirector
|
GrantCommon Stock | 14,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000051 · wk-form4_1716496365.xml · nonDerivative · entry 1 Huennekens R Scott · CIK 0001365493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,150 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:34 UTC |
Carruthers WendyDirector
|
GrantCommon Stock | 10,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000054 · wk-form4_1716496448.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,160 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:33 UTC |
Hulit Barbara B.Director
|
GrantCommon Stock | 10,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000052 · wk-form4_1716496393.xml · nonDerivative · entry 1 Hulit Barbara B. · CIK 0001682154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,370 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 20:19 UTC |
Hulit Barbara B.Director
|
GrantCommon Stock | 13,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000037 · wk-form4_1713298734.xml · nonDerivative · entry 1 Hulit Barbara B. · CIK 0001682154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,285 F1 · shares: The restricted stock units ("RSUs") were granted pursuant to a Consulting Agreement dated January 2, 2024 between Ms. Hulit and the Company. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:18 UTC |
Hulit Barbara B.Director
|
GrantCommon Stock | 11,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000030 · wk-form4_1710796701.xml · nonDerivative · entry 1 Hulit Barbara B. · CIK 0001682154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,220 F1 · shares: The restricted stock units ("RSUs") were granted pursuant to a Consulting Agreement dated January 2, 2024 between Ms. Hulit and the Company. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 23:00 UTC |
Befidi RobertPresident, Diagnostics
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 21,910 | $0.00 Strike: $22.65 | $0.00 |
DisclosureSEC source: 0001757073-24-000025 · wk-form4_1709074842.xml · derivative · entry 3 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,910 Underlying: Common Stock · 21,910 shares Expires 2034-02-25 F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 23:00 UTC |
Befidi RobertPresident, Diagnostics
|
GrantPerformance Share Unit · Derivative | 17,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000025 · wk-form4_1709074842.xml · derivative · entry 2 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,260 Underlying: Common Stock · 17,260 shares Expires not disclosed F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 23:00 UTC |
Befidi RobertPresident, Diagnostics
|
GrantCommon Stock | 9,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000025 · wk-form4_1709074842.xml · nonDerivative · entry 1 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,245 F1 · shares: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:01 UTC |
Kaabi Faez CChief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,620 | $0.00 Strike: $22.65 | $0.00 |
DisclosureSEC source: 0001757073-24-000029 · wk-form4_1709074903.xml · derivative · entry 3 Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,620 Underlying: Common Stock · 20,620 shares Expires 2034-02-25 F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:01 UTC |
Kaabi Faez CChief Accounting Officer
|
GrantCommon Stock | 30,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000029 · wk-form4_1709074903.xml · nonDerivative · entry 2 Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,630 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:01 UTC |
Kaabi Faez CChief Accounting Officer
|
Tax withholdingCommon Stock | 1,505 | $22.65 | $34,088.25 |
DisclosureSEC source: 0001757073-24-000029 · wk-form4_1709074903.xml · nonDerivative · entry 1 Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,715 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSUs"). Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 23:01 UTC |
Keller StephenPrincipal Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,460 | $0.00 Strike: $22.65 | $0.00 |
DisclosureSEC source: 0001757073-24-000027 · wk-form4_1709074875.xml · derivative · entry 3 Keller Stephen · CIK 0001993880 · Principal Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,460 Underlying: Common Stock · 15,460 shares Expires 2034-02-25 F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 23:01 UTC |
Keller StephenPrincipal Financial Officer
|
GrantCommon Stock | 11,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000027 · wk-form4_1709074875.xml · nonDerivative · entry 2 Keller Stephen · CIK 0001993880 · Principal Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,553 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 23:01 UTC |
Keller StephenPrincipal Financial Officer
|
Tax withholdingCommon Stock | 1,562 | $22.65 | $35,379.30 |
DisclosureSEC source: 0001757073-24-000027 · wk-form4_1709074875.xml · nonDerivative · entry 1 Keller Stephen · CIK 0001993880 · Principal Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,508 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:00 UTC |
Aghdaei AmirDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 113,370 | $0.00 Strike: $22.65 | $0.00 |
DisclosureSEC source: 0001757073-24-000023 · wk-form4_1709074816.xml · derivative · entry 4 Aghdaei Amir · CIK 0001410055 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,370 Underlying: Common Stock · 113,370 shares Expires 2034-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:00 UTC |
Aghdaei AmirDirector · Chief Executive Officer
|
GrantPerformance Share Unit · Derivative | 133,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000023 · wk-form4_1709074816.xml · derivative · entry 3 Aghdaei Amir · CIK 0001410055 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,985 Underlying: Common Stock · 133,985 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:00 UTC |
Aghdaei AmirDirector · Chief Executive Officer
|
GrantCommon Stock | 48,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000023 · wk-form4_1709074816.xml · nonDerivative · entry 2 Aghdaei Amir · CIK 0001410055 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,565 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:00 UTC |
Aghdaei AmirDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 33,367 | $22.65 | $755,762.55 |
DisclosureSEC source: 0001757073-24-000023 · wk-form4_1709074816.xml · nonDerivative · entry 1 Aghdaei Amir · CIK 0001410055 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,995 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSUs"). Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:01 UTC |
Nance Mark EGeneral Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 29,640 | $0.00 Strike: $22.65 | $0.00 |
DisclosureSEC source: 0001757073-24-000028 · wk-form4_1709074892.xml · derivative · entry 4 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,640 Underlying: Common Stock · 29,640 shares Expires 2034-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:01 UTC |
Nance Mark EGeneral Counsel
|
GrantPerformance Share Unit · Derivative | 23,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000028 · wk-form4_1709074892.xml · derivative · entry 3 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,350 Underlying: Common Stock · 23,350 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:01 UTC |
Nance Mark EGeneral Counsel
|
GrantCommon Stock | 21,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000028 · wk-form4_1709074892.xml · nonDerivative · entry 2 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,972 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:01 UTC |
Nance Mark EGeneral Counsel
|
Tax withholdingCommon Stock | 2,600 | $22.65 | $58,890.00 |
DisclosureSEC source: 0001757073-24-000028 · wk-form4_1709074892.xml · nonDerivative · entry 1 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,442 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 23:01 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,040 | $0.00 Strike: $22.65 | $0.00 |
DisclosureSEC source: 0001757073-24-000026 · wk-form4_1709074855.xml · derivative · entry 4 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,040 Underlying: Common Stock · 18,040 shares Expires 2034-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.